|
|
|
Elotuzumab Phase 1 / 2 Study Results Accepted for Oral Presentation REDWOOD CITY, CA--(Marketwire - News) today announced that data for the company's elotuzumab and TRU-016 development programs will be presented at the American...
Research findings, 'A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses,' are discussed in a new report. According to recent research from Northern Ireland UK, "Recently...
Mark Weiss, M.D., will join the Thomas Jefferson University, Department of Medical Oncology as Director of Hematologic Malignancies. Dr. Weiss will be professor of Medical Oncology at Jefferson Medical College of Thomas...
"Health states were developed based on literature; patient forum discussions; and were validated by a hematologist . Face-to-face interviews used the feeling thermometer Visual Analogue Scale (VAS) and the Time Trade-Off (TTO)...
Investigators publish new data in the report 'Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.' "Data from the International Collaborative...
VILLA GUARDIA , Italy----Gentium S.p.A. announced today that results from the Company’s Phase II/III Pediatric Prevention trial and Phase III Treatment trial for Defibrotide of Hepatic Veno-Occlusive Disease will be presented...
Researchers detail in 'Histiocytosis disorders in Northeast Egypt: epidemiology and survival studies (a 5-year study),' new data in histiocytosis. According to a study from Mansoura, Egypt, "Histiocytosis disorders include a...
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease...
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced...
— Photo: D.Gopalakrishnan Traditional start: Mammen Chandy, professor of Haematology, CMC Hospital, inaugurating the conference in Vellore on Thursday. Reena Bose, president, Nursing Research Society of India (third from...
